Davenport & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Sell
42,602
-1,354
-3% -$118K 0.02% 422
2026
Q1
$3.75M Sell
43,956
-727
-2% -$64.8K 0.02% 396
2025
Q4
$3.53M Buy
44,683
+1,096
+3% +$85.9K 0.02% 406
2025
Q3
$3.48M Buy
43,587
+151
+0.3% +$12.9K 0.02% 410
2025
Q2
$3.95M Sell
43,436
-308
-0.7% -$28.1K 0.02% 365
2025
Q1
$4.1M Buy
43,744
+608
+1% +$54.4K 0.02% 335
2024
Q4
$3.92M Buy
43,136
+361
+0.8% +$34.4K 0.02% 344
2024
Q3
$4.44M Sell
42,775
-184
-0.4% -$18.8K 0.03% 315
2024
Q2
$4.17M Sell
42,959
-549
-1% -$50.6K 0.03% 321
2024
Q1
$3.92M Buy
43,508
+777
+2% +$65.8K 0.02% 331
2023
Q4
$3.41M Sell
42,731
-822
-2% -$61.8K 0.02% 324
2023
Q3
$3.1M Buy
43,553
+163
+0.4% +$12.2K 0.02% 312
2023
Q2
$3.34M Buy
43,390
+2,153
+5% +$167K 0.02% 312
2023
Q1
$3.1M Sell
41,237
-1,413
-3% -$105K 0.02% 323
2022
Q4
$3.36M Sell
42,650
-389
-0.9% -$29.2K 0.03% 303
2022
Q3
$3.02M Buy
43,039
+763
+2% +$59.8K 0.03% 298
2022
Q2
$3.39M Sell
42,276
-1,147
-3% -$89.7K 0.03% 294
2022
Q1
$3.29M Sell
43,423
-1,873
-4% -$148K 0.02% 319
2021
Q4
$3.87M Sell
45,296
-3,170
-7% -$248K 0.03% 300
2021
Q3
$3.66M Buy
48,466
+2,844
+6% +$226K 0.03% 290
2021
Q2
$3.71M Sell
45,622
-2,909
-6% -$238K 0.03% 249
2021
Q1
$3.83M Buy
48,531
+3,793
+8% +$297K 0.04% 213
2020
Q4
$3.83M Sell
44,738
-106
-0.2% -$8.77K 0.04% 208
2020
Q3
$3.46M Sell
44,844
-1,022
-2% -$77.9K 0.04% 192
2020
Q2
$3.36M Buy
45,866
+1,762
+4% +$125K 0.04% 185
2020
Q1
$2.93M Sell
44,104
-7,731
-15% -$545K 0.04% 182
2019
Q4
$3.57M Buy
51,835
+8,263
+19% +$563K 0.04% 201
2019
Q3
$3.12M Sell
43,572
-279
-0.6% -$20.2K 0.04% 198
2019
Q2
$3.14M Sell
43,851
-189
-0.4% -$13.4K 0.04% 195
2019
Q1
$3.02M Sell
44,040
-184
-0.4% -$11.9K 0.04% 195
2018
Q4
$2.63M Buy
44,224
+54
+0.1% +$3.38K 0.04% 198
2018
Q3
$2.96M Sell
44,170
-3,320
-7% -$221K 0.03% 206
2018
Q2
$3.08M Sell
47,490
-3,923
-8% -$257K 0.04% 197
2018
Q1
$3.69M Buy
51,413
+1,144
+2% +$82.3K 0.05% 179
2017
Q4
$3.79M Buy
50,269
+6,487
+15% +$474K 0.05% 174
2017
Q3
$3.19M Sell
43,782
-1,752
-4% -$126K 0.04% 179
2017
Q2
$3.38M Buy
45,534
+1,708
+4% +$127K 0.04% 173
2017
Q1
$2.87M Sell
43,826
-264
-0.6% -$18.5K 0.04% 186
2016
Q4
$2.88M Buy
44,090
+383
+0.9% +$26.3K 0.04% 178
2016
Q3
$3.24M Buy
43,707
+1,677
+4% +$124K 0.05% 168
2016
Q2
$3.08M Sell
42,030
-600
-1% -$42.7K 0.05% 170
2016
Q1
$3.01M Sell
42,630
-33
-0.1% -$2.2K 0.05% 166
2015
Q4
$2.84M Sell
42,663
-1,796
-4% -$119K 0.05% 176
2015
Q3
$2.82M Buy
44,459
+593
+1% +$38.7K 0.05% 176
2015
Q2
$2.87M Sell
43,866
-372
-0.8% -$25.2K 0.04% 182
2015
Q1
$3.07M Sell
44,238
-293
-0.7% -$20.3K 0.05% 189
2014
Q4
$3.08M Sell
44,531
-2,373
-5% -$160K 0.05% 183
2014
Q3
$3.06M Buy
46,904
+74
+0.2% +$4.88K 0.05% 177
2014
Q2
$3.19M Buy
46,830
+413
+0.9% +$27.7K 0.05% 173
2014
Q1
$3.01M Sell
46,417
-1,574
-3% -$99.2K 0.05% 173
2013
Q4
$3.13M Buy
47,991
+455
+1% +$29.1K 0.06% 163
2013
Q3
$2.82M Sell
47,536
-2,471
-5% -$146K 0.06% 163
2013
Q2
$2.86M Buy
+50,007
New +$2.97M 0.06% 154

Other funds holding CL

Davenport & Co's CL Position: Q2 2026 in Review

Davenport & Co reduced its Colgate-Palmolive (CL) stake by 3.1% in Q2 2026, selling an estimated $118K and leaving 42,602 shares worth $3.91M. The position accounts for 0.02% of the portfolio, ranked #422.

Davenport & Co first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.44M in Q3 2024. 440 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Davenport & Co held 42,602 shares of Colgate-Palmolive worth $3.91M as of Q2 2026.
  • Davenport & Co sold 1,354 Colgate-Palmolive shares in Q2 2026, an estimated $118K.
  • Colgate-Palmolive made up 0.02% of Davenport & Co's portfolio in Q2 2026, its #422 holding.
  • Davenport & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Colgate-Palmolive position peaked at $4.44M in Q3 2024.
  • 440 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.